Malignant pleural effusion in NSCLC, molecular pathogenesis, and management strategies maintaining the pipes
Sara Salah1, Mohyeldin S Abdelhalim2, Waleed Arafat3
Author Email This email address is being protected from spambots. You need JavaScript enabled to view it.
Introduction: Malignant pleural effusion (MPE), known as cancer cells reaching the pleural space, usually indicates the presence of advanced disease. Lung cancer is a major contributing cause for malignant pleural effusion (MPE). Treatment is mainly fixed on addressing the palliative measures and improving the patient’s symptoms without providing any radical solution to the primary pathogenesis of the disease
Aim: To utterly understand the mechanism of metastasis and cancer progression in the case of MPE, it should be stated that in normal conditions, cells are consistently subjected to physical forces affecting the function as well as the phenotype of cells. These forces apply active or passive mechanical stress to all cells responsible for the hemodynamic stability of lung inflation and vascular perfusion. A variety of forces can apply such pressure on lung parenchymal cells and in different forms like changes in stress or strain and shear stress.
Method: The cellular response to these forces is purely the function of intracellular signaling that enables the cell to communicate the information to its interior. Mechanotransduction simply implies the transformation of the mechanical induced changes into biochemical signals which eventually alter gene expression and cell fate. Malignant transformation implies errors in the mechanotransduction pathway that leads to aberrant cellular behavior and the activation of key signaling pathways that drive phenotypical switching into more mesenchymal-like cancer cells from normal cells. Malignant cells promote the EMT with loss of the E-cadherin proteins which allow cells to escape into spaces or other sites. E-cadherin mutations have been strongly correlated with the EGFR pathway. Realignment of E-cadherin through histone deacetylases has led to enhanced sensitivity of the resistant NSCLC cell lines to gefitinib. Acquired resistance to gefitinib or osimeritinib in NSCLC cells has been correlated with the expression of EMT. In-addition, Yes-Associated Protein (YAP) and Transcriptional Co-activator with PDZ-binding Motif (TAZ) play an important role in the mechanotransduction process. YAP/TAZ are regulators of the transcription process, and they are the key master of the Hippo signaling pathway. It has been linked to not only the pathogenesis of lung cancer but also to the progression of the tumor and its metastasis.
Results: Finally, Novel modalities targeting the mechanotransdution process is currently pioneering the field of research.
Conclusion: More in-depth analysis is urgently needed and targeting the mechanotransduction mechanism and tumor micro-environment may play a major role in the near future.
Impact of Neutrophil-lymphocyte ratio and Albumin-Globulin ratio on the outcome of women with metastatic breast cancer.
Shereen Elshorbagy; Assistant professor of medical oncology, Faculty of Medicine, Zagazig University, Zagazig, Egypt., Rana Ebied; Resident of medical oncology, Al Ahrar Teaching hospital, Zagazig/ Egypt, Ola Elfarargy; Assistant professor of medical oncology, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
This email address is being protected from spambots. You need JavaScript enabled to view it. , This email address is being protected from spambots. You need JavaScript enabled to view it., This email address is being protected from spambots. You need JavaScript enabled to view it.
Author mobile: +201027539777
Introduction: Breast cancer is the most frequent malignancy among women all over the globe. The cancer related inflammation-based markers in Peripheral blood such as neutrophil-lymphocyte ratio (NLR) and albumin/globulin ratio (AGR) is a simple and cost-effective measure that correlates with cancer patient prognosis and treatment response.
Aim: This study aims to determine progression free survival (PFS) and overall survival (OS) of (NLR) and (AGR) in women with metastatic breast cancer(MBC) considering other clinical variables.
Patients and methods: This study retrospectively analyzed sixty female patients diagnosed with MBC either de novo or post early presentation treatment, whose were treated according to their primary physician plan with hormonal therapy, chemotherapy and or targeted therapy in medical oncology department Zagazig university from January 2015 to December 2017. Inclusion criteria were female patients diagnosed with MBC aged ≥ 18 years with available full data are included. Patients suffering from malignancy other than Breast Cancer (BC), male BC patients or cases with incomplete data were excluded from the study then was analyzed by Kaplan -Meier and cox regression methods.
Results: Kaplan-Meier method and Survival curves were found negative significant difference between NLR level with cutoff (>1.9) and OS of patients(p=<0.001). Univariate analysis showed positive significant difference between AGR with cut-off value (≤ 1.1) and (OS);( p=<0.001), with inverse statistical correlation between NLR and AGR. On the other side, there were neither statistically significant differences between NLR nor AGR and PFS with p-value (0.987, 0.297) respectively. Cox regression analysis was performed to ascertain that no statistically significant differences between clinicopathologic criteria of our studied patients with OS and PFS.
Conclusion: Our study suggested that NLR and AGR are significant prognostic biomarkers for (OS) in patients with MBC, low AGR/ high NLR are related to poor overall survival with no association with other parameters. An indirect inverse significant correlation was noticed between NLR and AGR., Cancer is different in each patient and personalized treatment should be a priority.
Sars-Cov-2 Vaccination hesitancy and attitude toward booster doses among breast cancer patients in Tunisia
Melliti R., Tbessi S., Chamsi A., Ouaz H., Belajouza S., Bouzid N., Tebra S.
Radiation oncology department, Farhat Hached Hospital, University of Sousse, Tunisia
Author Email This email address is being protected from spambots. You need JavaScript enabled to view it. Author mobile +21654823732
Introduction: Cancer patients are at a high risk of infection by COVID-19 virus. Then, SARS COV-2 vaccination is highly recommended.
Aim: We aim to evaluate breast cancer patients’ willingness to take COVID-19 vaccination and to identify predictive factors influencing their decision in order to promote vaccine uptake rates.
Method: A unicentric, cross-sectional anonymous survey conducted on voluntary cancer patients with breast cancer regardless of the tumor stage or current oncological treatment, attending the ambulatory care unit of the radiation oncology department of Farhat Hached Hospital of Sousse from September 2021 to December 2021.
Results: A total of 202 were included. Median age was 53,2 years [28-74]. 89.4% of patients were not vaccinated against the seasonal flu within the last 5 years. Patients were under oncological treatment in 81.8% of cases (n=108) including 18.5% under chemotherapy. Complete remission was found in 116 patients (87.9%). Patients had attracted COVID-19 infection in 31.8% of cases and were vaccinated in 57.6% of cases. Fifty patients refused taking the vaccine (37.8%) and 68 patients refused to take the vaccine’s booster dose (51.5%). Reasons for rejecting COVID19 vaccination were fear of vaccine’s side effects (p<0.001), fear of inefficacity of the vaccine for cancer patients (p=0.001) and lack of confidence on the governmental authorities (p=0.001). Waiting for the majority to get the vaccine (p<0.001) as well as the end of the oncological treatment (p=0.02) were associated to the hesitancy of receiving the booster dose.
Conclusion: Breast cancer patients adherence to vaccination is acceptable when hesitancy to take the booster dose is not negligeable. Health care providers as well as the government should play a role to highlight the importance for COVID-19 vaccination.
Abbreviated concurrent chemoradiotherapy in node-negative muscle-invasive bladder cancer
Balata R, Hemeda R, Metwally MI, Malek MM, Elshorbagy S, Mandour D
Author Email This email address is being protected from spambots. You need JavaScript enabled to view it. Author mobile +201064500480
Introduction Bladder cancer represents a major economic burden in Egypt, ranking as the second most common tumor in males 12.7%. Therefore, the goal of this research is to develop a hypofractionated treatment regimen that achieves a similar response at a lower cost and with less strain on the radiation machines.
Aim The aim of this study is to evaluate treatment outcome of hypofractionated concurrent chemo-radiotherapy using weekly cisplatin in muscle-invasive bladder cancer (MIBC).
Method From September 2019 till February 2021, 40 patients with node-negative muscle-invasive transitional cell carcinoma of the bladder, stage T2-T3N0M0, underwent maximal transurethral resection of bladder tumor followed by 3-dimensional conformal radiotherapy to the bladder in 45 Gy in 15 fractions with a weekly cisplatin dose of 30mg/m2. Treatment outcome was assessed by response and toxicity.
Results With a median follow-up time of 13 months (8-18 months), forty patients with a median age of 55.9 ± 8.4 years completed their treatment regimen. After 3 months of therapy, 26 patients (65%) had a complete local response, whereas 6 patients (15%) had progressive disease, 4 patients (10%) had local recurrence and 2 patients (5%) had with distant metastasis. Acute grade 3 gastrointestinal and genitourinary toxicities were 5% and 12.5% of all acute toxicities, respectively. 2.5% of patients had late grade 3 genitourinary toxicity. There were no reports of life-threatening complications or grade 4 toxicity.
Conclusion In node-negative bladder cancer, concurrent chemo-radiotherapy is a feasible and well-tolerated alternative to surgery. In addition to lower morbidity, this regimen offers effective treatment with low cost. However, T2 masses which were completely resected yielded better results.